Validation of a comorbidity index for use in obstetric patients: A nationwide cohort study

被引:21
|
作者
Bliddal, Mette [1 ,2 ]
Moller, Soren [1 ,2 ]
Vinter, Christina A. [1 ,3 ]
Rubin, Katrine H. [1 ,2 ]
Gagne, Joshua J. [4 ,5 ]
Pottegard, Anton [6 ]
机构
[1] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[2] Odense Univ Hosp, OPEN Open Patient Data Explorat Network, JB Winslow Vej 9a, DK-5000 Odense C, Denmark
[3] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark
[4] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, Odense, Denmark
关键词
adverse maternal outcomes; comorbidity; obstetric comorbidity index; prediction; reproduction; validation; DANISH; DIAGNOSES; REGISTRY; RISK;
D O I
10.1111/aogs.13749
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction A previously developed Obstetric Comorbidity Index has been validated in highly selected cohorts. Validation of the index in an unselected population as well as in other health registers is, however, of high importance to determine external validity. Material and methods Using nationwide registers, we formed a nationwide cohort including completed pregnancies (both live- and stillborn) in Denmark from 2000 through 2014. Maternal age and 20 comorbid conditions were assessed and weighted. Outcomes were maternal end-organ injury or death within 30 days postpartum. The index's predictive and discriminative ability was estimated by Brier score and the area under the receiver operating characteristic curve (AUC), respectively. Logistic regression analysis was used to estimate odds ratios (OR) with 95% confidence interval (CI). Results In 876 496 completed pregnancies by 527 079 women, 1.40% (n = 12 314) experienced an outcome. The majority of women (64.1%) did not have any record of a condition included in the index and only 0.3% (n = 3044) had a score >6. The incidence of an outcome increased with increasing comorbidity score from 0.9% (95% CI 0.8-0.9) in women scoring 0% to 10.4% (95% CI 7.6-13.9) in women scoring 9-10. Compared with women scoring 0, a score of 1-2 yielded an OR of 2.34 (95% CI 2.25-2.44), 3-4 an OR of 5.16 (95% CI 4.81-5.54), 5-6 an OR of 4.84 (95% CI 4.31-5.44), and 8-9 an OR of 7.97 (95% CI 6.54-9.72) for experiencing the outcome. The index had a Brier score of 0.01 and an AUC of 0.64. Conclusions Despite potential weaknesses in the outcome definition, the Obstetric Comorbidity Index showed a moderate ability to discriminate and predict end-organ injury and death in a nationwide cohort in Denmark, in accordance with previous findings. These results suggest that the index may be a useful tool to control for confounding in health research and clinically to identify women at high risk for adverse maternal outcomes.
引用
收藏
页码:399 / 405
页数:7
相关论文
共 50 条
  • [31] Risk of Delayed Discharge and Reoperation of Gastric Bypass Patients with Psychiatric Comorbidity-a Nationwide Cohort Study
    Lagerros, Ylva Trolle
    Brandt, Lena
    Sundbom, Magnus
    Hedberg, Jakob
    Boden, Robert
    OBESITY SURGERY, 2020, 30 (07) : 2511 - 2518
  • [32] Validation of the prognostic burn index: A nationwide retrospective study
    Tagami, Takashi
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    BURNS, 2015, 41 (06) : 1169 - 1175
  • [33] The Obstetric Comorbidity Index predicts severe maternal morbidity
    Bateman, B. T.
    Gagne, J. J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (13) : 1756 - 1756
  • [34] Adapting the Charlson Comorbidity index for use in patients with ESRD
    Hemmelgarn, BR
    Manns, BJ
    Quan, H
    Ghali, WA
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (01) : 125 - 132
  • [35] Validation of the Charlson comorbidity index in patients with head and neck cancer: A multi-institutional study
    Singh, B
    Bhaya, M
    Stern, J
    Roland, JT
    Zimbler, M
    Rosenfeld, RM
    HarEl, G
    Lucente, FE
    LARYNGOSCOPE, 1997, 107 (11): : 1469 - 1475
  • [36] A cohort study of comorbidity in patients with granulomatosis with polyangiitis
    Li, Lin
    Neogi, Tuhina
    Jick, Susan
    RHEUMATOLOGY, 2018, 57 (02) : 291 - 299
  • [37] A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study
    Kanda, Eiichiro
    Kato, Akihiko
    Masakane, Ikuto
    Kanno, Yoshihiko
    PLOS ONE, 2019, 14 (03):
  • [38] Body Mass Index and Outcomes in Patients with Takotsubo Syndrome: A Nationwide Retrospective Cohort Study
    Isogai, Toshiaki
    Okada, Akira
    Morita, Kojiro
    Michihata, Nobuaki
    Makito, Kanako
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    CARDIOLOGY, 2024, 149 (04) : 314 - 324
  • [39] Validation of the Rheumatic Disease Comorbidity Index
    England, Bryant R.
    Sayles, Harlan
    Mikuls, Ted R.
    Johnson, Dannette S.
    Michaud, Kaleb
    ARTHRITIS CARE & RESEARCH, 2015, 67 (06) : 865 - 872
  • [40] Development and Validation of a Pediatric Comorbidity Index
    Sun, Jenny W.
    Bourgeois, Florence T.
    Haneuse, Sebastien
    Hernandez-Diaz, Sonia
    Landon, Joan E.
    Bateman, Brian T.
    Huybrechts, Krista F.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2021, 190 (05) : 918 - 927